323 related articles for article (PubMed ID: 12198371)
21. [Protective effect and mechanism of hepcidin in rats with alcoholic liver damage].
Ji Y; Zhang YN; Kang XX; Xu YQ; Wang C
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):301-4. PubMed ID: 21586231
[TBL] [Abstract][Full Text] [Related]
22. Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels.
R'zik S; Loo M; Beguin Y
Haematologica; 2001 Mar; 86(3):244-51. PubMed ID: 11255270
[TBL] [Abstract][Full Text] [Related]
23. Determination of serum carbohydrate-deficient transferrin in the diagnosis of alcoholic liver disease.
Liu YS; Xu GY; Cheng DQ; Li YM
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):265-8. PubMed ID: 15908327
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical determination of hepatic cytochrome P-4502E1 in formalin-fixed, paraffin-embedded sections.
Cohen PA; Mak KM; Rosman AS; Kessova I; Mishin VM; Koivisto T; Lieber CS
Alcohol Clin Exp Res; 1997 Sep; 21(6):1057-62. PubMed ID: 9309318
[TBL] [Abstract][Full Text] [Related]
25. Microheterogeneity with concanavalin A affinity of serum transferrin in patients with alcoholic liver disease.
Inoue T; Yamauchi M; Toda G; Ohkawa K
Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):363A-365A. PubMed ID: 8986239
[TBL] [Abstract][Full Text] [Related]
26. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
[TBL] [Abstract][Full Text] [Related]
27. Chronic iron overload stimulates hepatocyte proliferation and cyclin D1 expression in rodent liver.
Brown KE; Mathahs MM; Broadhurst KA; Weydert J
Transl Res; 2006 Aug; 148(2):55-62. PubMed ID: 16890145
[TBL] [Abstract][Full Text] [Related]
28. [Transferrin receptor and iron deposition pattern in the hepatic lobules of the iron-deficient and iron-overloaded rats].
Lu J; Hayashi K; Hu X
Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):75-7. PubMed ID: 7788730
[TBL] [Abstract][Full Text] [Related]
29. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
30. Iron accumulation in alcoholic liver diseases.
Kohgo Y; Ohtake T; Ikuta K; Suzuki Y; Hosoki Y; Saito H; Kato J
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):189S-93S. PubMed ID: 16344607
[TBL] [Abstract][Full Text] [Related]
31. Hepatic sinusoidal macrophages in alcoholic liver disease.
Mills LR; Scheuer PJ
J Pathol; 1985 Oct; 147(2):127-32. PubMed ID: 3906065
[TBL] [Abstract][Full Text] [Related]
32. Quercetin prevents ethanol-induced iron overload by regulating hepcidin through the BMP6/SMAD4 signaling pathway.
Tang Y; Li Y; Yu H; Gao C; Liu L; Chen S; Xing M; Liu L; Yao P
J Nutr Biochem; 2014 Jun; 25(6):675-82. PubMed ID: 24746831
[TBL] [Abstract][Full Text] [Related]
33. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease.
Ahmed A; Saksena S; Sherlock M; Olliff SP; Elias E; Stewart PM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):898-903. PubMed ID: 18031327
[TBL] [Abstract][Full Text] [Related]
34. Alcoholic liver disease in alcoholic chronic pancreatitis: a prospective study.
Gullo L; Casadei R; Campione O; Grigioni W; Marrano D
Ital J Gastroenterol; 1995 Mar; 27(2):69-72. PubMed ID: 7579594
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.
Imbert-Bismut F; Naveau S; Morra R; Munteanu M; Ratziu V; Abella A; Messous D; Thabut D; Benhamou Y; Poynard T
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):18-27. PubMed ID: 19011575
[TBL] [Abstract][Full Text] [Related]
36. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets.
Li LX; Guo FF; Liu H; Zeng T
Cell Mol Life Sci; 2022 Mar; 79(4):201. PubMed ID: 35325321
[TBL] [Abstract][Full Text] [Related]
37. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
38. Lack of hepatic transferrin receptor expression in hemochromatosis.
Sciot R; Paterson AC; Van den Oord JJ; Desmet VJ
Hepatology; 1987; 7(5):831-7. PubMed ID: 3308665
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases.
Ohhira M; Ohtake T; Matsumoto A; Saito H; Ikuta K; Fujimoto Y; Ono M; Toyokuni S; Kohgo Y
Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):145S-149S. PubMed ID: 9622393
[TBL] [Abstract][Full Text] [Related]
40. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
